Recherche
-
Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis
(Multiple Sclerosis and Related Disorders. vol. 57, pp. 103385, 2022-01)Article de revueLibre accès -
Differential vulnerability of thalamic nuclei in multiple sclerosis
(Multiple Sclerosis Journal, 2022-08-12)Article de revueLibre accès -
Untreated patients with multiple sclerosis: a study of French expert centers
(European Journal of Neurology. vol. 28, n° 6, pp. 2026-2036, 2021-06)Article de revueLibre accès -
Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)
(Multiple Sclerosis and Related Disorders. vol. 48, 2021-02)Article de revueLibre accès -
Validation of a Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS) and comparison with reference batteries
(2022)Document de travail - Pré-publicationLibre accès -
Comparative effectiveness of dimethyl fumarate in multiple sclerosis
(British Journal of Clinical Pharmacology, 2021-03)Article de revueLibre accès